$155.1M in CY2024 Part D spend48K claims · 8K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Fingolimod used for?
indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patient....
Is there a generic for Fingolimod?
Yes. 14 ANDAs filed at FDA, 14 generic manufacturers currently shipping.
How much does my plan pay for Fingolimod?
Across 329 Part D plans, Fingolimod averages $4.79/unit (NADAC). Lowest available: $4.79/unit. Highest in distribution: $4.79/unit.
Is Fingolimod on the FDA shortage list?
No. Fingolimod is not currently on the FDA Drug Shortage Database.
5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (11 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.